Safety Information

Description Publish Date LINKS
Important safety information on Abacavir: Hypersensitivity reaction - educational slide deck
15/02/2024
Important safety information on Non-steroidal anti-inflammatory drugs (NSAlDs) in Congo 11/06/2021
Important safety information on Resorcinol in Congo 23/02/2022
Important safety information on Paroxetine in Congo (Safety Notification_EMA communication issued relating to Paroxetine label update) 27-10-2023
Important safety information on Cefuroxime sodium in Congo (Safety Notification_Cefuroxime Class 4 Defect MHRA) 30-10-2023
Important safety information on Topical Corticosteroids containing products in Congo 15-11-2023

Important safety information on Zanamivir containing products - Precautions for prescribing and administering flu medications (zanamivir)

29/12/2023

Important safety information on Paroxetine containing products - Modifications of the information of medicines authorized by national procedure that contain Paroxetine

28/12/2023